Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INO-3112 in HPV-associated HNSCC
NCT02163057Phase 2Completed
- Sponsor
- Inovio Pharmaceuticals, Inc.
- Start
- Aug 2014
- Primary completion
- Jan 2017
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of MEDI0457 in head and neck squamous cell carcinoma (HNSCC), sponsored by Inovio Pharmaceuticals, Inc.. Started Aug 2014; status: completed.
02
Drugs
MEDI0457
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02163057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02163057.